Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review.

Authors:
Hung SW; Zhang R; Tan Z; Chung JPW; Zhang T and 1 more

Journal:
Med Res Rev

Publication Year: 2021

DOI:
10.1002/med.21802

PMCID:
PMC8252000

PMID:
33948974

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Med Res Rev

Abbreviation: Med Res Rev

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Biofabrication approaches and regulatory framework of metastatic tumor-on-a-chip models for precisi…
Nieto D; Jiménez G; Moroni L and 3 more (2022) - Transparency Score: 3/6
Cardiovascular therapeutics: A new potential for anxiety treatment?
Repova K; Aziriova S; Krajcirovicova K and 1 more (2022) - Transparency Score: 2/6
Mutations of TRPM8 channels: Unraveling the molecular basis of activation by cold and ligands.
Plaza-Cayón A; González-Muñiz R; Martín-Martínez M. (2022) - Transparency Score: 3/6
Skin cancer, including related pathways and therapy and the role of luteolin derivatives as potenti…
Juszczak AM; Wöelfle U; Končić MZ and 1 more (2022) - Transparency Score: 3/6
Discovery of K<sub>V</sub> 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenge…
Gubič Š; Hendrickx LA; Toplak Ž and 7 more (2021) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTERESTS Chi Chiu Wang is an active member of the World Endometriosis Society and an advisor of the Aptorum Group."

Evidence found in paper:

"This study was supported by General Research Fund from Research Grants Council, Hong Kong (475012); Health and Medical Research Fund from Food and Health Bureau, Hong Kong (03141386); Innovation and Technology Fund from Innovation and Technology Commission, Hong Kong (ITS/209/12); UGC Direct Grant from The Chinese University of Hong Kong, Hong Kong (2011.2012); HKOG Trust Fund, Hong Kong (2011, 2014, 2019); and National Natural Science Fund from National Natural Science Foundation of China, China (81974225)."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025